共 50 条
- [2] Multi -Institutional Update on Bridging Radiotherapy in Relapsed or Refractory Large B-Cell Lymphoma Patients Prior to CAR T-Cell Therapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E606 - E606
- [3] Long-Term Outcomes of Salvage Radiation Therapy in Relapsed/ Refractory Large B- Cell Lymphoma Patients After CAR T-Cell Therapy Failure CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S608 - S608
- [6] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
- [7] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
- [8] Patients with Relapsed/Refractory Large Cell Lymphoma Who Were Also Refractory to Salvage Chemotherapy: Outcome with Salvage Radiation Therapy Followed by Autologous Stem Cell Transplant INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S125 - S125
- [9] Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1776 - 1780
- [10] Modified R-DAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 61 - 61